Daniel F Carr (Dan Carr, Munir Pirmohamed, D F Carr)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Transcription Factor

Emergency Department

Top Venues

British journal of clinical pharmacology

The British journal of dermatology

Experimental biology and medicine (Maywood, N.J.)

The Journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel F Carr, Anita Hanson
Stevens-Johnson syndrome/toxic epidermal necrolysis: international consensus, advances and opportunities. The British journal of dermatology (2024)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Dan Carr, Gary Maartens, Daniel F Carr, Christopher Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomised controlled trial of N-acetylcysteine for treatment of anti-tuberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Daniel F Carr, Gary Maartens, Munir Pirmohamed, Christopher E P Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Gospel Nwikue, Anna Olsson-Brown, Nourah Aboheimed, Vincent L M Yip, Carol Jolly, Andreea Luchian, Lorenzo Ressel, Anurag Sharma, Wilma Bergfeld, Shaheda Ahmed, Anne M Dickinson, Munir Pirmohamed, Daniel F Carr
TNF-α induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis. The Journal of dermatology (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Daniel F Carr, Gary Maartens, Munir Pirmohamed, Christopher E P Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Daniel F Carr, Gary Maartens, Munir Pirmohamed, Christopher E P Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Daniel F Carr, Richard M Turner, Munir Pirmohamed
Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response. British journal of clinical pharmacology 87 (2) (2020)
Vincent L M Yip, Henry Pertinez, Xiaoli Meng, James L Maggs, Daniel F Carr, B Kevin Park, Anthony G Marson, Daniel F Carr
Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. British journal of clinical pharmacology 87 (6) (2020)
Daniel F Carr, C-W Wang, T Bellón, L Ressel, G Nwikue, V Shrivastava, W Bergfeld, A L Jorgensen, W-H Chung, M Pirmohamed
Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. The British journal of dermatology 181 (1) (2019)
Daniel F Carr, Munir Pirmohamed
Biomarkers of adverse drug reactions. Experimental biology and medicine (Maywood, N.J.) 243 (3) (2017)